| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.15 | 0.007 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.1 | 0.07 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.1 | 0.07 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.092 | 0.1 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.08 | 0.2 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.074 | 0.2 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.065 | 0.3 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.051 | 0.3 |